Abstract
The healthspan-promoting drug rapamycin has important anti-inflammatory actions. This study demonstrated that, when transiently administered to middle-aged mice, it significantly reshapes the gut microbiota, leading to increased abundance of segmented filamentous bacteria in the small intestine.